Tech Company Financing Transactions
Pluristyx Funding Round
On 7/6/2026, Pluristyx raised Series A investment from private investors.
Transaction Overview
Company Name
Announced On
7/6/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The funding will allows us to rapidly expand our innovative platform, grow the company, and enable our customers to treat patients suffering from currently intractable diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3000 Western Ave
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Overview
Established in 2018 as an advanced therapy tools company, Pluristyx helps companies and researchers solve manufacturing challenges in the field of drug development, regenerative medicine, and cell and gene therapy. Pluristyx has provided seamless support through CMC consulting, contract development services, and research- and clinical-grade Ready-to-Use (RTU�) and Ready-To-Differentiate (RTD®) Pluripotent Stem Cells at a commercial scale.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Fryer
Chief Operating Officer
Jason Carstens
Chief Technical Officer
Brian Hawkins
VP - Finance
James Laing
Browse more venture capital transactions:
Prev: 7/6/2026: CurifyLabs venture capital transaction
Next: 7/6/2026: Katalyze AI venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs